(Q41587169)

4 October 2017

1 reference

title

Interference with antigen processing by viruses (English)

1 reference

4 October 2017

Hengel H

1

1 reference

PubMed ID

9287180

4 October 2017

Koszinowski UH

series ordinal

2

1 reference

PubMed ID

9287180

4 October 2017

language of work or name

1 reference

1 August 1997

1 reference

Current Opinion in Immunology

4 October 2017

1 reference

4 October 2017

9

1 reference

4 October 2017

470-476

1 reference

4 October 2017

4

1 reference

Generation, translocation, and presentation of MHC class I-restricted peptides

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Generation, intracellular transport and loading of peptides associated with MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Express yourself or die: peptides, MHC molecules, and NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Molecular mechanisms of variation in influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A viral inhibitor of peptide transporters for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Herpes simplex virus turns off the TAP to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Oligomeric Rings of the Sec61p Complex Induced by Ligands Required for Protein Translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytomegalovirus inhibits antigen presentation by a sequential multistep process

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980097-0

7 January 2021

10.1016/S0952-7915(97)80097-0

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9287180